FDA inspection
Chengdu Shuode Pharmaceutical Co., Ltd: FDA inspection ending Apr 18, 2023
FDA inspection 1215816 · Voluntary Action Indicated (VAI) · Chengdu
Key facts
| Inspection ID | 1215816 |
|---|---|
| Firm | Chengdu Shuode Pharmaceutical Co., Ltd |
| FEI number | 3018360274 |
| Address | No. 9 Lekang Road, Shuangliu District |
| City | Chengdu |
| Fiscal year | 2023 |
| Inspection end date | Apr 18, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data